These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16996675)

  • 1. Actinide speciation in relation to biological processes.
    Ansoborlo E; Prat O; Moisy P; Den Auwer C; Guilbaud P; Carriere M; Gouget B; Duffield J; Doizi D; Vercouter T; Moulin C; Moulin V
    Biochimie; 2006 Nov; 88(11):1605-18. PubMed ID: 16996675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future radionuclide speciation studies in biological media.
    Ansoborlo E; Bion L; Doizi D; Moulin C; Lourenco V; Madic C; Cote G; Van der Lee J; Moulin V
    Radiat Prot Dosimetry; 2007; 127(1-4):97-102. PubMed ID: 17578878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actinide geochemistry: from the molecular level to the real system.
    Geckeis H; Rabung T
    J Contam Hydrol; 2008 Dec; 102(3-4):187-95. PubMed ID: 19008017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinide and metal toxicity to prospective bioremediation bacteria.
    Ruggiero CE; Boukhalfa H; Forsythe JH; Lack JG; Hersman LE; Neu MP
    Environ Microbiol; 2005 Jan; 7(1):88-97. PubMed ID: 15643939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pentavalent actinide solution chemistry in the environment.
    Topin S; Aupiais J
    J Environ Radioact; 2016 Mar; 153():237-244. PubMed ID: 26808225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators.
    Durbin PW
    Health Phys; 2008 Nov; 95(5):465-92. PubMed ID: 18849679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of time-resolved laser fluorescence spectroscopy to the environmental biogeochemistry of actinides.
    Collins RN; Saito T; Aoyagi N; Payne TE; Kimura T; Waite TD
    J Environ Qual; 2011; 40(3):731-41. PubMed ID: 21546659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy.
    Fritsch P; Grémy O; Hurtgen C; Bérard P; Grappin L; Poncy JL
    Radiat Prot Dosimetry; 2011 Mar; 144(1-4):371-5. PubMed ID: 21131659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of chemical speciation to internal dosimetry.
    Paquet F; Frelon S; Cote G; Madic C
    Radiat Prot Dosimetry; 2003; 105(1-4):179-84. PubMed ID: 14535231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the use of speciation techniques and ab initio modelling to understand tetravalent actinide behavior in a biological medium: An(IV)DTPA case.
    Aupiais J; Bonin L; Den Auwer C; Moisy P; Siberchicot B; Topin S
    Dalton Trans; 2016 Mar; 45(9):3759-70. PubMed ID: 26817812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of geometries for in vivo measurements of actinides in the skull.
    Vrba T
    Appl Radiat Isot; 2010; 68(4-5):918-21. PubMed ID: 20223415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEDOR, a didactic tool to support interpretation of bioassay data after internal contamination by actinides.
    Mièle A; Blanchin N; Raynaud P; Quesne B; Giraud JM; Fottorino R; Bérard P; Ansoborlo E; Franck D; Blanchardon E; Challeton-de Vathaire C; Lebaron-Jacobs L; Poncy JL; Piechowski J; Fritsch P
    Radiat Prot Dosimetry; 2007; 127(1-4):350-5. PubMed ID: 17562646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO).
    Abergel RJ; Durbin PW; Kullgren B; Ebbe SN; Xu J; Chang PY; Bunin DI; Blakely EA; Bjornstad KA; Rosen CJ; Shuh DK; Raymond KN
    Health Phys; 2010 Sep; 99(3):401-7. PubMed ID: 20699704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicoordinate ligands for actinide/lanthanide separations.
    Dam HH; Reinhoudt DN; Verboom W
    Chem Soc Rev; 2007 Feb; 36(2):367-77. PubMed ID: 17264937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinide Decorporation: A Review on Chelation Chemistry and Nanocarriers for Pulmonary Administration.
    Lai EPC; Li C
    Radiat Res; 2022 Oct; 198(4):430-443. PubMed ID: 35943882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative radiological impact from a reactor accident in the case of emerging nuclear fuels.
    Nicolaou G
    Health Phys; 2009 Aug; 97(2):157-62. PubMed ID: 19590275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of actinide mass embedded in large concrete waste packages by photon interrogation and photofission.
    Gmar M; Jeanneau F; Lainé F; Makil H; Poumarède B; Tola F
    Appl Radiat Isot; 2005; 63(5-6):613-9. PubMed ID: 15982895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Take a Swipe at Actinide Bioavailability: Application of a New In Vitro Method.
    Griffiths NM; Moureau A; Coudert S; Huet F; Defrance M; Van der Meeren A
    Health Phys; 2023 Jun; 124(6):495-507. PubMed ID: 37022177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions.
    Kullgren B; Jarvis EE; An DD; Abergel RJ
    Toxicol Mech Methods; 2013 Jan; 23(1):18-26. PubMed ID: 22957518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an Acellular Assay to Study Interactions between Actinides and Biological or Synthetic Ligands.
    Van der Meeren A; Berthomieu C; Moureau A; Defrance M; Griffiths NM
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.